Prevention of Iron Deficiency in 2nd Year of Life

Soroka University Medical Center

Status and phase: Unknown; Phase 4

Conditions: Anemia; Iron Deficiency

Treatments: Drug: Ferripel-3 - iron polysaccharide complex for prevention

Study type: Interventional

Funder types: Other

Identifiers

NCT00479102

sor448707ctil

Details and patient eligibility

About

Healthy babies(age 8-18 months) following a routine blood count, with no anemia or iron deficiency, will be randomly placed in two groups. Group 1 will receive a 3 months preventive dose of an iron preparation (Ferripel 3 iron polysaccharide complex). Group 2 will be followed up as a control group. Following a nutritional questionnair, parents of all babies will receive instruction regarding appropriate nutrition in the 2nd year of life. A follow-up blood count will be taken from all participating babies 3 months after recruitment. The study aims to evaluate effectiveness of iron supplementation in the 2nd year of life. The hypothesis is that babies who receive iron supplementation in the 2nd year of life are less likely to develop iron deficiency or anemia.

Sex: All

Ages: 8 to 18 months old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy babies without iron deficiency

Exclusion criteria

• Babies with iron deficiency or chronic diseases, premature babies and babies with hereditary hematological disease

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)